We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Working Towards Better Anti-cancer Drugs

News   Jan 29, 2020 | Original story from the University of Bayreuth

 
Working Towards Better Anti-cancer Drugs

CAPTION Felix Klatt and Dr. Claus-D. Kuhn (r.) while working with High Five insect cells. Credit: Juli Eberle.

 
 
 

RELATED ARTICLES

New Worm Model To Progress Study of Rare Disease

News

The IDIBELL Neurometabolic Diseases group, with international collaboration, has identified a model of chromosome X-linked adrenoleukodystrophy (x-ALD) in the earthworm C. elegans, this is a rare disorder of the nervous system with no treatment available.

READ MORE

Statins Could Lower Ovarian Cancer Risk

News

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

READ MORE

Targeting Turncoat Immune Cells To Tackle Cancer

News

A newly published study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt their metabolism to thrive in the tumor microenvironment. This mechanism, is exclusively engaged by regulatory T cells (Tregs) that reside in tumors and could be disrupted to boost the effects of cancer immunotherapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE